Unlabelled: A combined myocardial performance index (isovolumic contraction time plus isovolumic relaxation time divided by ejection time, 'Tei-Index') has been applied in the echocardiographic evaluation of patients with dilated cardiomyopathy (DCM). N-terminal pro brain natriuretic peptide (NTproBNP) is released from the left ventricular (LV) in response tomyocite stretch and is a powerful prognostic marker for heart failure.
Aim: To assess the correlation between Tei index and NTproBNP level in patients with DCM.
Methods: Conventional echocardiography were performed in 50 consecutive patients with DCM, in sinus rhythm, concomitant with NTproBNP determination. Patients with paced rhythm and creatinine clearance < 40 mL/min were not included. Tei index was calculated.
Results: Simple regression analysis demonstrated a statistically significant linear correlation between NTproBNP and Tei index (r = 0.70, p < 0,001). NTproBNP had weaker relationship with pulmonary artery systolic pressure, indexed left atrial (LA) volume, LA volume, LV ejection fraction, early diastolic transmitral velocity (E) and no relationship with LA diameter, mitral E deceleration time, LV end-diastolic diameter. The area under the ROC curve for prediction of NTproBNP levels > 900 pg/mL was maxinal (0.76) for Tei index. The optimal Tei index cut-off for prediction of NTproBNP levels > 900 pg/mL was 0.77 (sensitivity = 84%, specificity = 82%).
Conclusions: Tei index strongly correlates with NTproBNP in patients with DCM in sinus rhythm, and can be a simple and accurate predictor of the serum NTproBNP level.
Download full-text PDF |
Source |
---|
Eur J Prev Cardiol
January 2025
Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Aims: We aimed to establish one-minute sit-to-stand test (1-min STST) cut-off values that align with the guideline-recommended six-minute walk test (6MWT) thresholds (165m and 440m) for one-year mortality risk stratification in pulmonary hypertension (PH) patients. Furthermore, we aimed to compare clinical characteristics and long-term mortality among patients stratified by these proposed 1-min STST cut-offs.
Methods: All patients performed the 1-min STST and 6MWT.
J Clin Med
January 2025
Clinical and Molecular Medicine Department, School of Medicine and Psychology, Sapienza University of Rome, 00189 Roma, Italy.
A healthy lifestyle plays a key role for maintaining the cardiovascular health (CVH) status and prevent cardiovascular disease occurrence. In fact, a healthy lifestyle was included in the AHA Cardiovascular Health score (Life's Simple 7 [LS7]), subsequently updated to Life's Simple 8 [LS8]. Apart from the importance of controlling conventional cardiovascular risk factors, increasing evidence supports the contributory role of cardiovascular hormones.
View Article and Find Full Text PDFJ Clin Med
January 2025
Department of Preventive Cardiology and Lipidology, Medical University of Lodz, 90-419 Lodz, Poland.
The Fontan operation has become the primary palliative treatment for patients with a functionally univentricular heart. The population of patients with Fontan circulation is constantly growing and aging. As the number of Fontan patients surviving into adulthood increases, there is a clear need for research on how best to follow these patients and manage their complications.
View Article and Find Full Text PDFBiomolecules
December 2024
Laboratory of Vascular Pathology and Diabetes, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Background: Plasma metabolites could be suitable as predictive biomarkers for cardiovascular pathologies or death, thereby improving the prediction of protein biomarkers. The release of acylcarnitines may be altered after coronary artery disease (CAD) in subjects with recurrent clinical outcomes, and this could be used as a prognosis tool.
Methods: Patients with stable coronary artery disease (SCAD) who had suffered an acute coronary syndrome 6-9 months before were followed for up to 4.
Chin J Nat Med
January 2025
Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Electronic address:
Astragali Radix (AR) and Notoginseng Radix et Rhizoma (NR) are frequently employed in cardiovascular disease treatment. However, the efficacy of the AR-NR medicine pair (AN) in improving cardiac remodeling and its underlying mechanism remains unclear. This study aimed to evaluate AN's cardioprotective effect and potential mechanism on cardiac remodeling using transverse aortic constriction (TAC) in mice and angiotensin II (Ang II)-induced neonatal rat cardiomyocytes (NRCMs) and fibroblasts in vitro.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!